Strategies and Solutions for Publication Planning and Execution Excellence - debated by pharmaceutical industry experts.
14 September 2007, NetworkPharma Ltd, Oxford, UK have published another in their KeywordPharma series of Conference Insights reports intended for individuals working in and around the global pharmaceutical industry.
Strategies and Solutions for Publication Planning and Execution Excellence: an in-depth report from The International Publication Planning Association’s 5th Annual Meeting held in San Francisco, CA, 25-26 June 2007 by Elizabeth Wager is now available for purchase.
The reputation of the global pharmaceutical industry is currently suffering, and there is public mistrust of drug companies’ publication practices. The industry can only eradicate this problem through increased transparency, honesty and openness in its publications. Clearly, the provision of unbiased information to medical decision makers is essential, not only for the sake of the industry's image, but, more importantly, for the good of public health.
In an environment of rapidly changing rules and regulations, pharmaceutical companies must develop their own robust publication policies that reflect the latest guidelines. Crucially, they must also develop compliance programmes to ensure that all those working on publications not only understand company policy, but actively implement it.
This Conference Insights review provides an in-depth review of the 5th Annual Meeting of The International Publication Planning Association held in San Francisco, CA, 25-26 June 2007. It details the major challenges facing publications professionals, including the need for disclosure, transparency and compliance. It offers guidance on how to develop and implement company policy, looks at the involvement of marketing in the publication process, the growth of open-access publishing and how agencies and drug companies can develop effective partnerships.
The author, Liz Wager, said: "The publication planning process requires cooperation from a diverse group of people and input from a number of different sources. Coordinating such teams and drawing together such information to create transparent, unbiased and educational documents for publication is a major challenge. Likewise, creating, maintaining and enforcing effective company policies can be challenging."
All KeywordPharma publications can be purchased from ThePharmYard at www.ThePharmYard.com
NOTES
About the author
Elizabeth (Liz) Wager is the author of books on 'Getting Research Published: An A to Z of Publication Strategy' and 'How to Survive Peer Review'. She is a co-author of 'Good Publication Practice for Pharmaceutical Companies' and the European Medical Writers Association guidelines on the role of medical writers. After obtaining a First Class zoology degree from Oxford in 1983 she worked for Blackwell Scientific Publications, Janssen-Cilag then Glaxo-Wellcome. In 2001, she set up her own company, Sideview, which provides training, writing, editing and publication consultancy services. She is a member of: the BMJ’s Ethics Committee, the World Association of Medical Editors Ethics Committee, the Council of the Committee on Publication Ethics, the editorial board of European Science Editing (the journal of the European Association of Science Editors) and the World Health Organization Scientific Advisory Group on trial registration.
Written by pharmaceutical industry specialists, KeywordPharma publications are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development. Available to purchase individually as e-documents, they build into a specialist knowledge library for everyone working in and around the global pharmaceutical industry.
Developed and managed by NetworkPharma Ltd, ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.
NetworkPharma Ltd is an independent, specialist company founded by Peter Llewellyn, to focus on novel approaches to disseminating information within the global medical and pharmaceutical industries. Peter Llewellyn previously founded and built the leading industry portal site, InPharm, which was subsequently purchased by John Wiley & Sons to manage alongside their other industry services, PharmaFile and Pharmafocus.
For more information contact:
For more information please contact us via our web site or directly contact Peter Llewellyn, Managing Director, NetworkPharma Ltd, email: peter@networkpharma.com, tel: +44 (0) 1865 865943
